IMNP
Immune Pharmaceuticals Inc.
IMNP
IMNP
Delisted
IMNP was delisted on the 25th of July, 2018.
17 hedge funds and large institutions have $183K invested in Immune Pharmaceuticals Inc. in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$34K | |
| 2 | +$30K | |
| 3 | +$11K | |
| 4 |
Goldman Sachs
New York
|
+$10K |
| 5 |
Bank of New York Mellon
New York
|
+$5K |
Top Sellers
| 1 | -$97.8K | |
| 2 | -$23K | |
| 3 | -$14K | |
| 4 |
JP Morgan Chase
New York
|
-$7K |